Hoping to make it easier for researchers to start clinical trials, the National Institutes of Health has proposed an ethical review policy that would allow a single institutional review board ruling to stand for a multi-institution group.
At present, a board oversees all human trials research taking place on its campus. Sally Rockey, the NIH’s deputy director for extramural research, notes on her blog that the rule was made when there was less collaboration between groups at different hospitals, universities and research centers.
“I believe this proposed policy is a step forward to reducing burdens associated with NIH-funded clinical research and enhancing the efficiency of the process,” she writes.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.